CAGRI + SEMA
Cagri + Sema – 5mg / 5mg (Lyophilized Peptide Blend)
Cagri + Sema is a dual peptide research combination consisting of Cagrilintide and Semaglutide, studied for its synergistic effects on metabolic regulation pathways. This combination is commonly explored in preclinical research focused on appetite signaling, glucose metabolism, and energy balance mechanisms.
Cagrilintide is a long-acting amylin analog, while Semaglutide is a GLP-1 receptor agonist. Together, they are researched for their complementary activity on satiety signaling and metabolic response pathways.
Product Details:
- Peptides: Cagrilintide + Semaglutide
- Ratio: 1:1 blend (5mg / 5mg total per vial)
- Form: Lyophilized powder
- Purity: >98%
- Quantity: 10mg total (combined) per vial
- Storage: Store at -4°F (-20°C). After reconstitution, refrigerate at 36–46°F (2–8°C) and use within 30 days.
Potential Research Applications:
- Appetite regulation and satiety signaling studies
- Glucose metabolism and insulin response research
- Body weight regulation and energy balance models
- Combination peptide pathway interaction studies (GLP-1 + Amylin pathways)







Reviews
There are no reviews yet.